|Last Price$66.25||Day Change (%)-1.27%|
|Open Price$66.47||Day Change ($)-0.85|
|Day Range65.25–66.47||52-Week Range60.84–92.35|
As of Tue 04/15/2014 03:00 PM EST | USD
Global Colocation Provider CyrusOne to Sponsor Ingram Micro Cloud Summit 2014
FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy to Reduce Bleeding Episodes with Prophylactic Infusions Starting at Least a Week Apart
Fitch Rates Digital Stout Holding, LLC's 4.75% Sr. Unsecured Guaranteed Notes due 2023 'BBB'
Nevis Capital Corporation Narrows Cannabis Acquisitions Candidates
Nevis Capital Corporation Negotiating For Entry into Cannabis Industry
Fitch Affirms Citigroup's 'A' L-T IDR; Viability Rating Upgraded to 'a', Outlook Stable
Empire Resources Declares 44th Consecutive Quarterly Dividend
Relevant questions (and answers) for investors as they continue their research into bankruptcy and pension issues.
Regulatory issues that we believe have little impact on Novo Nordisk's long-run prospects have finally helped shares of the leading insulin maker go on sale.